Document gbb329BNjV8q1DkJ59mGdLKgJ

CHEMICAL MANUFACTURERS ASSOCIATION Vinyl Chloride Health Committee Record of Conference Call Date: Time: October 24, 1994 9:30 a.m. List of Participants: James Barter Ed Beeler Ron Gilbert Mark Gruenwald James Knaak Joe Ledvina Patrick Logue David Pun Jonathan Ramlow PPG Industries The GEON Company Westlake Polymers Borden Chemicals and Plastics Occidental Chemical Vista Chemical Georgia Gulf Corporation Formosa Plastics Dow Chemical Has Shah CMA 1.0 Has Shah reviewed his conversation with Bryan Riedel of EPA regarding the ATSDR/EPA research data needs for vinyl chloride. According to Mr, Riedel, the neurotoxicity testing was recommended by the Clean Air Office. Mr. Riedel has expressed a willingness to meet with industry representatives to discuss technical issues before submitting a testing proposal to EPA. 2.0 The Committee agreed to retain a counsel to represent its interests with ATSDR and EPA. The Committee recommended retaining Caffey Norman of Patton Boggs LLP because of his knowledge of similar issues with the Halogenated Solvents Industry Alliance. Dr. Shah will convey the Committee's recommendation to CMA's General Counsel for approval. 3.0 The Committee agreed to award the epidemiology study update contract to Kenneth Mundt of Applied Epidemiology Inc. Jonathan Ramlow will discuss technical issues identified by the Committee with Dr. Mundt and identify areas of cost savings. Dr. Shah then will follow-up with Dr. Mundt to obtain a revised cost proposal from Applied Epidemiology Inc. 4.0 The Committee agreed to the October 12,1994 budget developed by Dr. Shah, which included $350,000 for the epidemiology study update, $20,000 for data transfer cost from ENSR to Applied Epidemiology Inc., and $30,000 for consultant services of Jonathan Ramlow of Dow Chemical. 5.0 The conference call concluded at approximately 11:30 a.m. Subject to Approval Hasmukh C. Shah, Ph.D. Manager, Vinyl Chloride Panel CMA 119430